CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Although prostate cancer screening has been embraced by ... treatment over antiandrogen monotherapy in the setting of locally advanced disease. This study reveals the importance of radiation ...

The 5-year survival rates for prostate cancer at various stages are as follows: Localized and regional: around 99% for both Black and white men Advanced disease: around 30% in Black and white men ...

Study finds uneven access to prostate cancer clinical trials. While Black men's enrollment was similar to White men, Hispanic ...

“Our study revealed that approximately 30% to 35% of nearly 16,000 men in the United Kingdom with high-risk localized or locally advanced prostate cancer did not receive potentially curative ...

This article provides an overview of developments in advanced prostate cancer and considers how the available options for lengthening survival for men with mCRPC may be sequenced.

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. A new study led by researchers at the UCLA Health ...

A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses. Published in Nature Communications ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies. Many cases of high-risk nonmetastatic hormone ...